Berkeley, United States
Aralez Bio is a forward-thinking startup that is pioneering the use of engineered enzymes to expand access to novel amino acids. Founded in 2019, the company is leveraging biocatalysis to offer sustainable and cost-effective alternatives in amino acid production. By utilizing its proprietary platform, Aralez Bio has managed to produce thousands of amino acids that were previously deemed too challenging and expensive to synthesize.
The company's mission is to continuously and affordably enhance human life by introducing noncanonical amino acids that drive the development of groundbreaking products. These innovations have the potential to benefit both people and the environment, making them a compelling investment target for those interested in sustainable biotechnology solutions.
Although specifics about its headquarters and recent investments remain undisclosed, Aralez Bio stands out as a high-potential entity in the biotech sector, poised to redefine how amino acids are utilized across industries.
